Identifying patients at risk: multi-centre comparison of HeartMate 3 and HeartWare left ventricular assist devices.

ABSTRACT:

Aims

Since the withdrawal of HeartWare (HVAD) from the global market, there is an ongoing discussion if and which patients require prophylactically exchange for a HeartMate 3 (HM3). Therefore, it is important to study outcome differences between HVAD and HM3 patients. Because centres differ in patient selection and standard of care, we performed a propensity score (PS)-based study including centres that implanted both devices and aimed to identify which HVAD patients are at highest risk.

Methods and results

We performed an international multi-centre study (n = 1021) including centres that implanted HVAD and HM3. PS-matching was performed using clinical variables and the implanting centre. Survival and complications were compared. As a sensitivity analysis, PS-adjusted Cox re

SUBMITTER: Numan L 

PROVIDER: S-EPMC10192248 | biostudies-literature | 2023 Jun

REPOSITORIES: biostudies-literature